Quality of life measurement in bone marrow transplantation: Development of the functional assessment of cancer therapy-bone marrow transplant (FACT-BMT) scale

被引:353
作者
McQuellon, RP
Russell, GB
Cella, DF
Craven, BL
Brady, M
Bonomi, A
Hurd, DD
机构
[1] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT PUBL HLTH SCI,WINSTON SALEM,NC 27157
[2] RUSH PRESBYTERIAN ST LUKES MED CTR,CHICAGO,IL 60612
关键词
quality of life; functional assessment; marrow transplantation;
D O I
10.1038/sj.bmt.1700672
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
We developed a 12-item bone marrow transplant subscale (BMTS) for the general Functional Assessment of Cancer Therapy (FACT) measure, The subscale combined with the FACT, (FACT-BMT) is a 47-item, valid and reliable measure of five dimensions of quality of life in bone marrow transplant patients, The three-step validation process involved the generation and selection of BMT-specific items and the testing of the overall measure, Items were selected from a list produced by seven oncology experts and 15 patients and were designed to assess content not represented in the general FACT items, A total of 182 patients completed the FACT-BMT at baseline, prior to BMT. An analysis measuring sensitivity to change was performed with 74 patients after transplantation and 60 patients over the three time-points of baseline, hospital discharge and 100 days, The FACT-BMT and all subscales were correlated, sensitivity to change was measured, and the internal consistency for each scale was calculated, Coefficients of reliability and validity ranged from 0.86 to 0.89 for the entire FACT-BMT and 0.54 to 0.63 for the BMTS. The BMTS was able to discriminate patients on the basis of performance status rating and also demonstrated sensitivity to change over time, The FACT-BMT has good psychometric properties for use in assessing quality of life in bone marrow transplant patients, The addition of the bone marrow transplant subscale to the general FACT measure makes it an excellent choice for use in BMT clinical trials.
引用
收藏
页码:357 / 368
页数:12
相关论文
共 37 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]  
ANDRYKOWSKI MA, 1995, BONE MARROW TRANSPL, V15, P837
[3]  
ANDRYKOWSKI MA, 1989, BONE MARROW TRANSPL, V4, P75
[4]   QUALITY-OF-LIFE FOLLOWING BONE-MARROW TRANSPLANTATION - FINDINGS FROM A MULTICENTER STUDY [J].
ANDRYKOWSKI, MA ;
GREINER, CB ;
ALTMAIER, EM ;
BURISH, TG ;
ANTIN, JH ;
GINGRICH, R ;
MCGARIGLE, C ;
HENSLEEDOWNEY, PJ .
BRITISH JOURNAL OF CANCER, 1995, 71 (06) :1322-1329
[5]   THE QUALITY OF LIFE IN ADULT SURVIVORS OF ALLOGENEIC BONE-MARROW TRANSPLANTATION - CORRELATES AND COMPARISON WITH MATCHED RENAL-TRANSPLANT RECIPIENTS [J].
ANDRYKOWSKI, MA ;
ALTMAIER, EM ;
BARNETT, RL ;
OTIS, ML ;
GINGRICH, R ;
HENSLEEDOWNEY, PJ .
TRANSPLANTATION, 1990, 50 (03) :399-406
[6]  
ANDRYKOWSKI MA, 1995, BONE MARROW TRANSPL, V15, P573
[7]  
ANDRYKOWSKI MA, 1994, BONE MARROW TRANSPL, V13, P357
[8]   PSYCHOSOCIAL FACTORS PREDICTIVE OF SURVIVAL AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA [J].
ANDRYKOWSKI, MA ;
BRADY, MJ ;
HENSLEEDOWNEY, PJ .
PSYCHOSOMATIC MEDICINE, 1994, 56 (05) :432-439
[9]  
[Anonymous], 1994, Manual: Functional Assessment of Cancer Therapy (FACT) Scales and Functional Assessment of HIV Infection (FAHI) Scale
[10]  
BEITZ J, 1996, MONOGR NATL CANC I, V20, P7